Superdisintegrants Market Analysis By Product (Croscarmellose sodium, Crospovidone, Sodium starch glycolate, Ion exchange resin), By Dosage Form (Tablets and Capsules, Mouth-dissolving Films), And Segment Forecasts, 2018 - 2025

Report Overview

The global superdisintegrants market size was valued at around USD 258.6 million in 2016 and is expected to grow at a CAGR of 7.2% over the forecast period. Factors such as growing generic drugs market, geriatric and pediatric population who have difficulty in swallowing tablet/capsules and development of new superdisintegrants for the pharmaceutical industry is driving the growth of the market.

Furthermore, increasing pharmaceutical consumption by the global population is in turn increasing the demand for various superdisintegrants. Pharmaceuticals now account for about 20% of total health spending in Organization for Economic Co-operation and Development (OECD) countries; out of which Canada has emerged out to be among the top pharmaceutical spender on the OECD list.

U.S. superdisintegrants market revenue, by product, 2014 - 2025 (USD Million)

Product Insights

Crospovidone dominated the product segment in 2016. Crospovidone has the ability to stabilize the amorphous state of drugs due to inhibition of drug recrystallization and a rapid solidification rate. In addition, crospovidone has excellent disintegration and dissolution enhancing effect, which is usually used in the preparation of tablets, granules, and capsules. All these factors would together propel the growth of the crospovidone segment during the forecast period.

However, the others segment which includes natural superdisintegrants such as Isapghula husk, gellan gum, and locust bean gum is expected to grow at the highest CAGR during the forecast period. It has instant swelling features when it comes into contact with water due to its high hydrophilic nature, which results in the rapid disintegration of tablets. Apart from these superdisintegrants, researchers are continuously investigating novel disintegrating agents. It includes testing of modified natural products, such as chitin, chitosan, polymerized agar acrylamide, xylem, cross-linked carboxymethyl guar, and modified tapioca starch.

Dosage Form Insights

Tablets and capsules segment dominated the market in 2016. Tablets have a longer shelf life, accurate dosing, and are cost-effective. Disintegrants are one of the most significant excipients of tablet and capsule formulation and are added to induce breakup when it encounters aqueous fluid. Tablets and capsules have quick-dissolving dosage form recognized by the FDA and are listed in the approved drug products with therapeutic equivalence evaluations, which would boost the growth of the segment. The number of disintegrants used for multifunctional tablet and capsule formulation includes starch (and its derivatives), crospovidone, cellulose, and others.

The Mouth-dissolving film segment is expected to witness the highest growth during the forecast period. Advantages and unique properties, availability of larger surface area for rapid disintegrating and dissolution in the oral cavity, accurate dosing, rapid onset of action, and improved patient compliance for the pediatric population are a few factors contributing towards the growth of the segment.

Global superdisintegrants market revenue, by product, 2016 (%)

Regional Insights

North America dominated the superdisintegrants industry with the largest revenue share in 2016. Increasing demand for generic drugs, better innovation in the manufacture of superdisintegrants, and the techniques used to manufacture them are a few high impact rendering drivers for the market. In addition, North America is home to some of the most significant players who are operating in the field of superdisintegrants market.

On the other hand, Asia Pacific is expected to show the fastest growth during the forecast period. Factors such as increasing outsourcing of excipients including superdisintegrants, manufacturing of new superdisintegrants, and adoption of novel technologies (novel drug delivery system) are expected to drive growth in the Asia Pacific region.

Competitive Insights

Currently, the global superdisintegrants market is fragmented in nature with a number of players. Some of the top companies operating in this industry are Ashland Global Holdings Inc., Roquette Frères S.A., FMC Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co., Ltd. The Dow Chemical Company and BASF SE. Mergers, acquisitions, and regional expansion are the key strategic undertakings of these companies to increase the market share during the forecast period.

Superdisintegrants Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels as well as provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global superdisintegrants market on the basis of product, dosage form, and region:

• Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Croscarmellose sodium

  • Crospovidone

  • Sodium starch glycolate

  • Ion exchange resin

  • Others

• Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)

  • Tablets and Capsules

  • Mouth-dissolving Films

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa